Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
False Claims Act
Fresenius Provides Insight As to Why It Terminated Acquisition of Akorn,…
On Wednesday, May 2, 2018, Fresenius made some allegations that shed light on why the company sought to terminate its acquisition…
Off-Label Promotion: Tennessee Becomes Second State to Allow Pharmaceutical…
Tennessee becomes the second state in the country permitting pharmaceutical companies, including its representatives, to engage in…
McKesson Accused of Illegally Handling Cancer Medications
On April 4, 2018, a lawsuit was unsealed that shows McKesson Corporation – America’s largest drug distributor and one of the top…
The Escobar Hurdle – False Claims, Materiality, and Dismissal
U.S. ex rel. Ruckh v. CMC II LLC et al. (“Ruckh”) was a closely followed False Claims Act case, because a Florida Federal Court…
Alere Settles False Claims Act Allegations for $33.2 Million
Massachusetts-based medical device manufacturer Alere (acquired by Abbott Laboratories in 2017) and its subsidiary Alere San Diego…
Taking Center Stage – Washington State’s Medicaid Fraud Control Unit,…
On July 26, 2017, the Washington State Attorney General (“AG”) Bob Ferguson (“Ferguson”) announced one of the State’s largest…
Fresenius to the U.S. Government: When It Comes to the FCA, You Snooze You…
In a nearly decade long lawsuit involving the dialysis company Fresenius, and allegations that the company violated the False…
False Claims Act Mid-Year Review: Significant Life Science Settlements,…
Several significant False Claims Act settlements and judgments in the first six months of 2017 suggest this year will result in…
FDA Warns Cipher Over “Misleading” Marketing Materials
The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent a warning letter to Cipher…
DOJ Announces Another FCA Settlement – Sightpath Medical and TLC…
In late August 2017, the United States Department of Justice (DOJ) announced a $12 million settlement with Sightpath Medical and…